T1	Participants 543 776	In an open-label, three-way crossover study, 24 healthy men were randomly assigned to receive 0.5 mg of risperidone twice daily, 5 mg of donepezil once daily, or both drugs for 14 consecutive days, followed by a 21-day washout period
T2	Participants 0 96	Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil
T3	Participants 112 131	Alzheimer's disease
